Pepdox
Studies
Peptides
Calculator
The semaglutide paradox in non-overweight diabetes: a benefit without explanation. | Pepdox
Home
/
Search
/
PMID 40796132
The semaglutide paradox in non-overweight diabetes: a benefit without explanation.
European heart journal. Quality of care & clinical outcomes
2025
PMID: 40796132
View on PubMed
DOI: 10.1093/ehjqcco/qcaf082
Semaglutide
Authors
Shamsulddin, Ahmed B